million dollar gene therapy
Jan 10, 2018
Snippet
Gene therapy is back into play after a decade-long failed deliveries. 2017 was a golden year in gene therapy arena, various companies are aggressively developing gene therapy based treatments targeting life-threatening indications. Spark therapeutics got USFDA approval for the first-ever gene therapy based blindness...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
